We noticed you are on our US page. Want to switch regions? Choose from the options:

  • Healthcare Professionals
  • Latest research
  • Publications
  • A Phase III Trial of 2 Years of Androgen Suppression and Radiation Therapy with or without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group (RTOG) Phase III Randomized Trial NRG Oncology RTOG 9902

A Phase III Trial of 2 Years of Androgen Suppression and Radiation Therapy with or without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group (RTOG) Phase III Randomized Trial NRG Oncology RTOG 9902